Experimental infection of goats by Pasteurella multocida B:2 by Saad, Mohd Zamri et al.
1. Vet. Malaysia (2005) 17 (2) 29 - 32
EXPERIMENTAL INFECTION OF GOATS BY PASTEURElLA. MULTOCIDA B:2
M. Zamri-Saad, N.M.D. Zaitun, A. Ernie and M.S. Shafarin
Facultyof Veterinary Medicine, Universiti Putra Malaysia,
43400 UPM Serdang, Selangor Darul Ehsan, Malaysia
SUMMARY
An experiment was carried out to determine whether goats can be infected by Pasteurella multocida B:2, the caus-
ative agent of haemorrhagic septicaemia of cattle and buffaloes. Thirty-six healthy local goats were divided into four
groups consisting of nine goats per group. Goats of groups 1 and 3 were inoculated intranasally with 1ml inoculum
containing 109 CFU of live P. multocida B:2. Goats of groups 2 and 4 were not infected, but were exposed to the
infected animals by keeping goats of group 2 together with group 1 while group 4 together with group 3. Immediately
post-infection, goats in groups 3 and 4 were treated with dexamethasone at the rate of 1mg/kg for three consecutive
days. Three goats from each of the four groups were killed on days 7,14 and 21 post-infection. One goat from group
3 died percutely on day 2 post-infection, showing lesions typical ofhaemorrhagic septicaemia. Other two goats from
the same group were weak. None of the goats in groups 1, 2 and 4 succumbed to the disease but most exhibited signs
of mild respiratory tract infection. Post-mortem examinations revealed that 20 (53 %) goats had mild, acute pneumo-
nia affecting less than 7% of the lung, suggesting that P. multocida B:2 is not a primary pathogen of the respiratory
tract. Four (11 %) goats of group 3 had pulmonary oedema and congestion, indicating that dexamethasone enhanced
chances of goats being infected by P. multocida B:2. P. multocida was successfully re-isolated from lungs and nasal
swabs of goats from all groups, and heart blood of goats from group 3 but not from the lymph nodes and tonsils. The
re-isolation of P. multocida B:2 was successfully made for up to 14 days p.i, in groups without dexamethasone but for
up to 21 days following dexamethasone treatment. Transmission of P. multocida B:2 to the in-contact goats occurred
at a rate of 40%.
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INTRODUCTION
Pasteurella multocida serotype B:2 (Carter:Heddleston)
is the bacterium responsible for haemorrhagic septi-
caemia (HS) in Asia, while serotype E:2 causes the dis-
ease in Africa. It is an acute, fatal septicaemic disease
affecting buffaloes and cattle, characterised by a short
clinical course lasting a few hours with signs of severe
depression, dypsnoea, submandibular oedema and
recumbency, followed by death (Horadagoda et al.,
2001). The high-morbidity, high-mortality nature of this
disease renders it to be the most important disease eco-
nomically in Southeast Asia, where it is epidemic (Jo-
seph, 1979). Annual losses of USD400-60oo in Indo-
nesia, USD 1.4 million in Laos and approximately
USD 1.0 million in Malaysia have been reported recently
(Verma nd Jaiswal, 1998). The disease has been known
to occur in many parts of the world, but is more frequently
reported in Middle and North East, central and South
Africa, and some European countries, besides Southeast
Asia.
Although haemorrhagic septicaemia is commonly
observed in buffaloes and cattle, it has also been reported
in other species of animals. The range of hosts includes
American bison, sheep and swine, deer, elephants, yaks,
horses and camels. Goats have been reported to be natu-
rally infected with haemorrhagic septicaemia (Interior,
1993). This study describes experimental infection of P.
multocida serotype B:2 in goats.
MATERIALS AND METHODS
Animals
Thirty-six clinically healthy local Katjang goats of about
8 months of age were selected. Prior to the start of the
experiment, nasal swabs were collected to ensure that
the goats were free from P. multocida B:2, treated with
anthelmintic (Levamisol, Boehringer) and were housed
together. They were fed daily with cut grass and
commercial goat pellets while drinking water was
available ad libitum.
Inoculum
Stock culture of P. multocida B:2, isolated from a
previous outbreak ofhaemorrhagic septicaemia in cattle,
was used. The bacteria was sub-cultured onto blood agar
at 37°C for 24 hours before five uniform-sized colonies
were selected and incubated in the brain heart infusion
broth for 18 hours at 37°C. The viable count of the
organism was 1x109 CFU/ml.
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Experimental procedures
"The goats were divided into four groups consisting of
nine goats per group. Goats of groups 1 and 3 were
inoculated intranasally with 1 rnl of the inoculum
containing 1.0xl09 CFU of P. multocida B:2. Goats of
groups 2 and 4 were not inoculated but exposed to the
infected animals by keeping goats of group 2 with group
1 and goats of group 4 with group 3. Immediately after
inoculation, goats of groups 3 and 4 were injected
intramuscularly with dexamethasone at the rate of Img/
kg for three consecutive days.
Following the infection, clinical signs and rectal
temperature were monitored daily and recorded. Post-
mortem examination was carried out on all dead goats.
Death within 48 hours post-infection was classified as
peracute, between 3 to 7 days as acute, between 8 to 14
days as subacute and between 15 to 21 days as chronic
infection. On days 7, 14 and 21 post-infection, three
goats from each group were killed for post-mortem
examination. The experimental procedure was in
accordance with the guidelines of the Committee of .
Institutional Animals, Faculty of Veterinary Medicine,
Universiti Putra Malaysia.
Sample processing
Samples of lung, lymph node, tonsil, nasal swab and
heart blood were taken aseptically for bacteriologi-
cal examination. They were cultured for the presence of
P. multocida on blood agar plates at 37° C for 24 hours.
RESULTS
Clinical observations
Only one goat of group 3 succumbed to the disease on
day 2 post-infection. The affected animal was found
weak and having fever. Two other goats in group 3 were
weak with fever. No sign of clinical haemorrhagic septi-
caemia was exhibited by other goats. However, allgoats, .
either infected or exposed, showed signs of mild respi-
ratory tract infection. They were coughing and sneez-
ing with nasal discharge; the highest body tempera-
ture recorded was 38.5° C..
Post-mortem examinations
The goat of group 3 that died 48 hours post-infection
showedcongestionofmost internal organ, includinglung,
spleen and liver. There was evidence of pulmonary
oedema.and hydrothorax. Two other goats 'of the same
group showed severe pulmonary .congestion and oedema
with slight hydrothorax. Examinations of other animals
revealed no sign of generalised congestion, haemorrhage
or oedema that indicated haemorrhagic septicaemia.
Table!: Percentage of pneumonic lung lesions in goats
following different treatment by P. multocida B:2
Animal group Treatment Average Lung Lesion (%)
1 Intranasal 5.4
2 Exposed 3.9
3 Intranasal with
4
Dexamethasone
Exposed with
Dexamethasone 4.6
5.7
Note: The differences in the average of lung lesions between the
different groups were insignificant (p>0.05)
However, the lungs of20 (53%) goats of various groups
showed varying degrees of acute pneumonia ranging
from 1-15% (Table 1). The pneumonic lesion was con-
fined to the right apical lobe of the lungs with only two
goats showing the lesions in the left apical lobe. The
lung lesions were observed until14 days post-infection.
Bacteriological examination
P. multocida B:2 was re-isolated in pure cultures from
lungs and nasal swabs of goats of groups 1 and 2 at days
.7 and 14 post-infection, but for up to day 21 post-
infection from goats of groups 3 and 4. Successful
re-isolations were obtained from 5 (56%) goats of group
1,4 (45%) goats of group 2, 5 (56%) goats of group 3
and 3 (33%) goats of group 4 (Table 2). Transmission of
P. multocida to exposed goats occurred at an average
rate of 40%. Re-isolation of P. multocida B:2 from heart
blood was successful in two goats of group 3.
DISCUSSION
The results of this study indicate that goats are
susceptible but relatively resistant to clinical disease of
haemorrhagic septicaemia following intranasal exposure.
The evidenced that only one goat was infected and
treated with dexamethasone died peracutely of the dis-
ease supports this observation. This has been observed
earlier by Wijewardana et al. (1986). Two other goats
with the same treatments were weak with pulmonary con-
gestion and oedema, indicating a milder form of
haemorrhagic septicaemia. However, the clinical signs
of respiratory tract infection, gross lesions in the lungs
and re-isolation of P. multocida B:2 proved that goats
can be infected by and transmit the organism. This is in
agreement with earlier observations (Loganathan and
Chandrasekaran, 1992).
The pneumonic lesions were acute but mild,
involving approximately 7% of the lung and confined to
the right apical lobe. This is similar to the mild acute
lung lesions reported in experimental haemorrhagic
septicaemia of cattle (Zamri-Saad and Saharee, 1990;
Erler and Schimmel,1993; Graydon et al., 1993), indi
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Table 2: Re-isolation of P.multocida 6:B from organ samples
of infected and in-contact goats~
Animal Days p.i AnimalID Re-isolation
group rate
1 7 2344 +
2577 +
1401
14 2576 +
2341 +
2581 +
21 2579
1461
2348
2 7 1405
2582 +
0269 +
14 2578 +
2345
0268 +
21 1464
1403
0244
3 7 0242 +
0267 +.
0246 +
14 0261
0250
0247 +
21 0249
0262
0265 +
4 7 0245
0201
0248 +
14 0241 +
0263
0266
21 0243
0270
0264 +
eating that P. multocida B:2 is not a primary lung patho-
gen. It may use the lung as a route to cause septicae-
mia since earlier reports showed that P. multocida B:2
reside in the pneumocytes (Horagoda and Belak, 1990),
survive intracellular environment and undergo exocyto-
sis (Galdiero et al., 2001) while dexamethasone treat-
ment failed to enhance the severity of lung lesions.
Most successful re-isolations of P. multocida were
made from the nasal swab and lungs. None of the goats
had the organism in the tonsils or lymph nodes,
contrasting the previous studies in cattle and buffaloes
(Wijewardana et al., 1986; De Alwis et al., 1990; Saharee
et al., 1993). Re-isolation was successful from 56% of
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the infected goats and from 40% of the exposed goats
but dexamethasone treatment prolonged the presence of
P. multocida in goats to 21 days post-infection.
Similarly, dexamethasone increased the number of goats
carrying P. multocida in the exposed group. A stressful
condition has been shown to enhance bacterial
infectivity leading to disease (Zamri-Saad et al., 1991;
Saharee et al., 1993). The complete absence of the
organism between days 14 and 21 post-infection may be
explained by the clearance mechanism of the respiratory
system, which support further the earlier claims that goats
are relatively resistant to P. multocida B:2 (Wijewardana
et al., 1986) and P. multocida B:2 is not a primary
pathogen of the respiratory tract (Zamri-Saad and
Saharee, 1990). It appears that P. multocida B:2 is able
to enter and multiply in the goat tissues but is unable to
resist the host defense mechanism leading to failure in
causing severe damage to the host. This is known as
subclinical infection (Baskerville, 1981). Dexamethasone
treatment prolonged infection and survival of the
organism leading to clinical disease (Loganathan and
Chandrasekaran, 1992).
REFERENCES
Baskerville, A. (1981). Mechanisms of infection in the
respiratory tract. New Zealand Vet. J. 29: 235-238
De Alwis, M.C.L., Wijewardana, T.G, Gomis, A.LU. and
Vipulasiri, A.A. (1990). Persistence of the carrier
status in haemorrhagic septicaemia (Pasteurella
multocida serotype 6:B infection) in buffaloes. Trop.
Anim. Hlth. Prod. 22: 185-194
Erler, W. and Schimmel, D. (1992). The effect of the
Pasteurella multocida toxin in calves. Pasteurello-
sis in Production Animals. ACIAR Proceedings No.
43. pp. 103-104
Galdiero, M., De Martino, L., Pagnini, U., Pisciotta, M.
and Galdiero, E. (2001). Interaction between bovine
endothelial cells and Pasteurella multocida: asso-
ciation and invasion. Res. Microbiol. 152: 57-65
Graydon, R.J., Patten, B.E. and Hamid, H. (1992). The
pathology of experimental haemorrhagic septicae-
mia in cattle and buffalo. Pasteurellosis in Produc-
tion Animals. ACIAR Proceedings No. 43. pp105-
107
Horadagoda, N.U. and Belak, K. (1990). Demonstration
of Pasteurella multocida Type 6:B (B:2) in forma-
lin-fixed paraffm-embedded tissues of buffaloes by
the peroxidase anti-peroxidase (PAP) technique. Acta
Veterinaria Scandanavica 31: 493-495
32 M. Zamri-Saad, N.M.D. Zaitun, A. Ernie and M.S. Shafarin
Horadagoda, N.U., Hodgson, J.C., Moon, G.M.,
Wijewardana, T.G. and Eckersall, P.O. (2001). Role
of endotoxin in the pathogenesis of haemorrhagic
septicaemia in the buffalo. Microbiol. Pathogenesis
30: 171-178
Interior, M.M. (1993). Country Report: Philippines.
Pasteurellosis in Production Animals. ACIAR Pro-
ceedings No.43, pp. 254-256
Joseph, P.G. (1979). Haemorrhagic septicaemia in
Peninsular Malaysia. Kajian Veterinar 11:65-79
Loganathan, P. and Chandrasekaran, S. (1992). Clini-
copathological changes in goats experimentally
infected with Pasteurella multocida and Pasteurella
haemolytica. Proceedings of the National IRPA
Seminar, pp. 20-21
Saharee, A.A., Salim, N.B., Rasedee, A. and Jainudeen,
M.R. (1993). Haemorrhagic septicaemia carriers
among cattle and buffalo in Malaysia. Pasteurello-
sis in Production Animals. ACIAR Proceedings No.
43. pp. 89-91
Verma, R. and Jaiswal, T.N. (1998). Haemorrhagic sep-
ticaemia vaccines. Vaccine 11112: 1184-1192
Wijewardana, T.G., De Alwis, M.C.L., and Vipulasiri,
A.A. (1986). An investigation into the possible role
of the goat as a host in haemorrhagic septicaemia.
Sri Lanka Vet. J. 34: 24-32
Zamri-Saad, M. and Saharee, A.A. (1990). The pathol-
ogy of experimental haemorrhagic septicaemia in
cattle. Trop. Vet. 8: 1-7
Zamri-Saad, M., Jasni, S., Nurlda,A.B and Sheikh-Ornar,
A.R., 1991. Experimental infection of dexametha-
sone-treated goats with Pasteurella haemolytica A2.
Bri. Vet. J. 147: 565-568
